Benjamin Barnes1, Daniel F Hanley, Juan R Carhuapoma. 1. Division of Neurosciences Critical Care, Departments of Neurology, Neurosurgery and Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Spontaneous intracerebral haemorrhage (ICH) imposes a significant health and economic burden on society. Despite this, ICH remains the only stroke subtype without a definitive treatment. Without a clearly identified and effective treatment for spontaneous ICH, clinical practice varies greatly from aggressive surgery to supportive care alone. This review will discuss the current modalities of treatments for ICH including preliminary experience and investigative efforts to advance the care of these patients. RECENT FINDINGS: Open surgery (craniotomy), prothrombotic agents and other therapeutic interventions have failed to significantly improve the outcome of these stroke victims. Recently, the Surgical Trial in Intracerebral Haemorrhage (STICH) II assessed the surgical management of patients with superficial intraparenchymal haematomas with negative results. MISTIE II and other trials of minimally invasive surgery (MIS) have shown promise for improving patient outcomes and a phase III trial started in late 2013. SUMMARY: ICH lacks a definitive primary treatment as well as a therapy targeting surrounding perihematomal oedema and associated secondary damage. An ongoing phase III trial using MIS techniques shows promise for providing treatment for these patients.
PURPOSE OF REVIEW: Spontaneous intracerebral haemorrhage (ICH) imposes a significant health and economic burden on society. Despite this, ICH remains the only stroke subtype without a definitive treatment. Without a clearly identified and effective treatment for spontaneous ICH, clinical practice varies greatly from aggressive surgery to supportive care alone. This review will discuss the current modalities of treatments for ICH including preliminary experience and investigative efforts to advance the care of these patients. RECENT FINDINGS: Open surgery (craniotomy), prothrombotic agents and other therapeutic interventions have failed to significantly improve the outcome of these stroke victims. Recently, the Surgical Trial in Intracerebral Haemorrhage (STICH) II assessed the surgical management of patients with superficial intraparenchymal haematomas with negative results. MISTIE II and other trials of minimally invasive surgery (MIS) have shown promise for improving patient outcomes and a phase III trial started in late 2013. SUMMARY:ICH lacks a definitive primary treatment as well as a therapy targeting surrounding perihematomal oedema and associated secondary damage. An ongoing phase III trial using MIS techniques shows promise for providing treatment for these patients.
Authors: H Arima; J G Wang; Y Huang; E Heeley; C Skulina; M W Parsons; B Peng; Q Li; S Su; Q L Tao; Y C Li; J D Jiang; L W Tai; J L Zhang; E Xu; Y Cheng; L B Morgenstern; J Chalmers; C S Anderson Journal: Neurology Date: 2009-12-08 Impact factor: 9.910
Authors: Charlotte Jj van Asch; Merel Ja Luitse; Gabriël Je Rinkel; Ingeborg van der Tweel; Ale Algra; Catharina Jm Klijn Journal: Lancet Neurol Date: 2010-01-05 Impact factor: 44.182
Authors: Geoffrey Appelboom; Samuel S Bruce; Zachary L Hickman; Brad E Zacharia; Amanda M Carpenter; Kerry A Vaughan; Andrew Duren; Richard Yeup Hwang; Matthew Piazza; Kiwon Lee; Jan Claassen; Stephan Mayer; Neeraj Badjatia; E Sander Connolly Journal: J Neurol Neurosurg Psychiatry Date: 2013-01-23 Impact factor: 10.154
Authors: L M Auer; W Deinsberger; K Niederkorn; G Gell; R Kleinert; G Schneider; P Holzer; G Bone; M Mokry; E Körner Journal: J Neurosurg Date: 1989-04 Impact factor: 5.115
Authors: W Andrew Mould; J Ricardo Carhuapoma; John Muschelli; Karen Lane; Timothy C Morgan; Nichol A McBee; Amanda J Bistran-Hall; Natalie L Ullman; Paul Vespa; Neil A Martin; Issam Awad; Mario Zuccarello; Daniel F Hanley Journal: Stroke Date: 2013-02-07 Impact factor: 7.914
Authors: Maged D Fam; Daniel Hanley; Agnieszka Stadnik; Hussein A Zeineddine; Romuald Girard; Michael Jesselson; Ying Cao; Lynn Money; Nichol McBee; Amanda J Bistran-Hall; W Andrew Mould; Karen Lane; Paul J Camarata; Mario Zuccarello; Issam A Awad Journal: Neurosurgery Date: 2017-11-01 Impact factor: 4.654
Authors: Yuko Y Palesch; Sharon D Yeatts; Thomas A Tomsick; Lydia D Foster; Andrew M Demchuk; Pooja Khatri; Michael D Hill; Edward C Jauch; Tudor G Jovin; Bernard Yan; Rüdiger von Kummer; Carlos A Molina; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Annie Simpson; Kit N Simpson; Joseph P Broderick Journal: Stroke Date: 2015-04-09 Impact factor: 7.914
Authors: Audrey Leasure; W Taylor Kimberly; Lauren H Sansing; Kristopher T Kahle; Golo Kronenberg; Hagen Kunte; J Marc Simard; Kevin N Sheth Journal: Curr Treat Options Neurol Date: 2016-02 Impact factor: 3.598
Authors: Alastair J S Webb; Natalie L Ullman; Tim C Morgan; John Muschelli; Joshua Kornbluth; Issam A Awad; Stephen Mayo; Michael Rosenblum; Wendy Ziai; Mario Zuccarrello; Francois Aldrich; Sayona John; Sagi Harnof; George Lopez; William C Broaddus; Christine Wijman; Paul Vespa; Ross Bullock; Stephen J Haines; Salvador Cruz-Flores; Stan Tuhrim; Michael D Hill; Raj Narayan; Daniel F Hanley Journal: Stroke Date: 2015-08-04 Impact factor: 7.914